Literature DB >> 29243835

Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.

Xiaoting Li1, Yu Meng1, Chunfeng Xie1, Jianyun Zhu1, Xiaoqian Wang1, Yuan Li1, Shanshan Geng1, Jieshu Wu1, Caiyun Zhong1,2, Min Li3.   

Abstract

Cancer stem cells (CSCs) play a central role in the development of breast cancer. The canonical Wnt/β-catenin signal pathway is critical for maintaining CSCs characteristics. Diallyl trisulfide (DATS), a natural organosulfur compound from the garlic, exhibits effective antitumor properties. However, the role of DATS in regulating breast CSCs activity and the underlying molecular mechanisms remain obscure. In the present study, we reported that DATS efficiently inhibited the viability of breast CSCs as evidenced by reducing turmorspheres formation, decreasing the expression of breast CSCs markers (CD44, ALDH1A1, Nanog, and Oct4), as well as inhibiting proliferation and inducing apoptosis. Furthermore, we showed that DATS downregulated the activity of Wnt/β-catenin pathway, while LiCl-triggered Wnt/β-catenin activation diminished DATS inhibition on breast CSCs. Taken together, our results illustrated that DATS suppressed breast CSCs through inhibiting Wnt/β-catenin pathway activation. These novel findings could provide new insights into the molecular mechanisms of breast CSCs regulation as well as its target intervention and might provide new strategies for preventing and treating breast cancers.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wnt/β-catenin pathway; breast cancer stem cells; diallyl trisulfide; inhibition

Mesh:

Substances:

Year:  2018        PMID: 29243835     DOI: 10.1002/jcb.26613

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.

Authors:  Marina Cruz-Lozano; Adrián González-González; Juan A Marchal; Esperanza Muñoz-Muela; Maria P Molina; Francisca E Cara; Anthony M Brown; Gerardo García-Rivas; Carmen Hernández-Brenes; Jose A Lorente; Pedro Sanchez-Rovira; Jenny C Chang; Sergio Granados-Principal
Journal:  Eur J Nutr       Date:  2018-11-21       Impact factor: 5.614

2.  Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide.

Authors:  Eun-Ryeong Hahm; Sivapar V Mathan; Rana P Singh; Shivendra V Singh
Journal:  J Cancer Prev       Date:  2022-06-30

Review 3.  Allium Vegetables Intake and Risk of Breast Cancer: A Meta-Analysis.

Authors:  Jinhang Zhang; Jing Yang
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

4.  Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.

Authors:  Su-Hyeong Kim; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2022-05-05       Impact factor: 5.139

Review 5.  Breast cancer stem cells: A review of their characteristics and the agents that affect them.

Authors:  Naing L Shan; Yoosub Shin; Ge Yang; Philip Furmanski; Nanjoo Suh
Journal:  Mol Carcinog       Date:  2021-01-11       Impact factor: 4.784

Review 6.  Cancer stem cell characteristics and their potential as therapeutic targets.

Authors:  Jacqueline R Lim; Josette Mouawad; Olivia K Gorton; William A Bubb; Ann H Kwan
Journal:  Med Oncol       Date:  2021-05-29       Impact factor: 3.064

7.  Gene Expression Changes by Diallyl Trisulfide Administration in Chemically-induced Mammary Tumors in Rats.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  J Cancer Prev       Date:  2022-03-30

8.  Multiple exposure to environmental factors and variations in CYP27B1 and the microRNA-binding site of IL-13 are associated with breast cancer risk.

Authors:  Nannan Zhang; Yanbo Chen; Shuo Li; Huihui Yin; Liangliang Li; Ming Shan; Zhiping Long; Jingshen Tian; Jing Li; Hongyuan Yu; Kun Xie; Zhen Wu; Volontovich Daria; Fan Wang; Yashuang Zhao
Journal:  Cancer Med       Date:  2019-04-30       Impact factor: 4.452

Review 9.  The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death.

Authors:  Vanessa Castelli; Antonio Giordano; Elisabetta Benedetti; Francesco Giansanti; Massimiliano Quintiliani; Annamaria Cimini; Michele d'Angelo
Journal:  Cancers (Basel)       Date:  2021-01-17       Impact factor: 6.639

Review 10.  Dietary Phytochemicals Targeting Cancer Stem Cells.

Authors:  Alena Liskova; Peter Kubatka; Marek Samec; Pavol Zubor; Milos Mlyncek; Tibor Bielik; Samson Mathews Samuel; Anthony Zulli; Taeg Kyu Kwon; Dietrich Büsselberg
Journal:  Molecules       Date:  2019-03-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.